×
Enzo Biochem - 41 Year Stock Split History | ENZ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Stock Price History
Stock Splits
Market Cap
The most recent stock split for Enzo Biochem (ENZ) was a
1.1:1 split
on October 21, 2004. The combined total of all historical stock splits for Enzo Biochem result in
1.9487171 current shares
for every original share available at the IPO in 1984.
View More
Enzo Biochem - 41 Year Stock Split History | ENZ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Stock Price History
Stock Splits
Market Cap
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$228.9B
Amgen (AMGN)
$158.1B
Gilead Sciences (GILD)
$134.2B
Vertex Pharmaceuticals (VRTX)
$121.1B
Bristol Myers Squibb (BMY)
$111.6B
CSL (CSLLY)
$80.7B
GSK (GSK)
$75.7B
Regeneron Pharmaceuticals (REGN)
$75B
Argenex SE (ARGX)
$38.9B
Alnylam Pharmaceuticals (ALNY)
$32.4B
BioNTech SE (BNTX)
$28.7B
BeiGene (ONC)
$23.2B
Biogen (BIIB)
$20B
Illumina (ILMN)
$16.3B
Insmed (INSM)
$15B
Genmab (GMAB)
$14.5B
Genmab (GNMSF)
$14.4B
Moderna (MRNA)
$13.8B
Intra-Cellular Therapies (ITCI)
$13.7B
Incyte (INCY)
$13.6B
BioMarin Pharmaceutical (BMRN)
$12.5B
Swedish Orphan Biovitrum (BIOVF)
$10.9B
Bio-Techne Corp (TECH)
$10.4B
Vaxcyte (PCVX)
$10.4B
Sarepta Therapeutics (SRPT)
$10.2B
Exelixis (EXEL)
$9.8B
Ascendis Pharma (ASND)
$9.4B
Exact Sciences (EXAS)
$9.3B
Bio-Rad Laboratories (BIO.B)
$8.7B
QIAGEN (QGEN)
$8.7B